Medinice S.A.
Other professional, scientific and technical activities, not elsewhere classified
Overview
Medinice develops advanced technologies for cardiac care, including CoolCryo, a cardiac ablation device, and PacePress. Its portfolio also includes AtriClamp for left atrial appendage occlusion, EP Bioptom for diagnostics and MiniMax, a diagnostic and therapeutic catheter. The company focuses on innovations in cardiology and cardiac surgery.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 76 days late). All were audited by a statutory auditor.
- 202514/07/2026
- 202414/07/2025
- 202303/07/2024
- 202203/07/2023
- 202129/09/2022
- 202008/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Stock quotes
- Open
- PLN 45.90
- High
- PLN 47.50
- Low
- PLN 45.20
- Volume
- 17K
- Avg. vol.
- 43.97K
- Market cap
- PLN 424.86M
- P/E ratio
- –
- EPS
- -PLN 1.02
- Shares outstanding
- 9.29M
- 52-week
- PLN 43.90 – 57.60
- Dividend yield
- –
- Dividend
- –
- Ex dividend date
- –
- ISIN
- PLMDNCE00016
- Exchange
- GPW Main Market
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q3 2026 | USD 5.13k | USD -1.01m | USD -983.52k |
| Q2 2026 | USD 15.13k | USD -680.98k | USD -708.54k |
| Q1 2026 | USD 14.59k | USD -323.61k | USD -325.23k |
| Q4 2025 | USD 14.82k | USD -797.84k | USD -800.85k |
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Medical electrotherapy devices
- Cardiac ablation devices
- Left atrial appendage occlusion devices
- Diagnostic catheters
- Diagnostic and therapeutic catheters
Websites
- medinice.plMedinice | Home page
Trademarks
The company holds 8 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2015.
| Mark | Protected until | |
|---|---|---|
| PacePress Care (word) | Nov 25, 2032 | |
| COOLBEE (word) | Aug 10, 2031 | |
| CathAIO (word) | Nov 8, 2028 | |
| PacePress (word) | Nov 8, 2028 | |
| Mediconsole (word) | Nov 8, 2028 |
Authorized Representatives
Manner of representation
If there is a one-person management board, the company is represented by 1 (one) member of the management board. If there is a multi-member management board, the company is represented by 2 (two) members of the management board acting jointly or by 1 (one) member of the management board acting jointly with a commercial proxy.
Supervisory board
Beneficial owners
Medinice is a public company listed on the Warsaw Stock Exchange, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.
Bank accounts
Registered as a VAT taxpayer on 2013-01-03.
76 1020 1013 0000 0102 0545 7157
85 1020 1013 0000 0102 0521 3816
43 1090 1883 0000 0001 6875 4575
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 4, 2022 | Commercial Companies Code notice | |
| Nov 15, 2018 | Commercial Companies Code notice | |
| Jun 11, 2018 | Shareholders' meeting convened | |
| Feb 15, 2017 | Shareholders' meeting convened | |
| Jan 19, 2017 | Shareholders' meeting convened |
Public aid
14 public aid cases recorded, with a total value of $2,023,993.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 4, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezydent Miasta Stołecznego Warszawy | |
| May 9, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Marszałek Województwa Mazowieckiego | |
| May 9, 2025 | Aid for research and development projects: experimental development | –– | Marszałek Województwa Mazowieckiego |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| F.R.K. Intra-Cordis sp. z o.o. | $215,043.19 | intracordis.com.pl | ||
| Quantum Innovations sp. z o.o. | $167,489.61 | quantuminnovations.pl | ||
| AUG Medical sp. z o.o. | $141,688.75 | augmedical.pl | ||
| Hagmed sp. z o.o. | $94,318.82 | hagmed.com | ||
| Spark Group sp. z o.o. | $75,379.54 | sparkgroup.com.pl | ||
| Ogarit sp. z o.o. | $48,793.46 | ogarit.pl | ||
| OPTI G sp. z o.o. | $34,289.31 | optig.pl | ||
| Zalimp Invest sp. z o.o. | $27,343.04 | zalimp.pl | ||
| SUMI sp. z o.o. | $21,015.77 | sumi.com.pl | ||
| Biotreat Vascular sp. z o.o. | $20,270.13 | biotreatvascular.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-07-23 | Share capital increase (910,999.60 PLN → 1,045,163.90 PLN) | |
| 2025-12-12 | Share capital increase (769,564.80 PLN → 910,999.60 PLN) | |
| 2025-06-18 | Share capital increase (766,229.10 PLN → 769,564.80 PLN) | |
| 2024-11-21 | Share capital increase (646,229.10 PLN → 766,229.10 PLN) | |
| 2023-05-25 | Share capital increase (627,257.50 PLN → 646,229.10 PLN) |
FAQ
Last updated: 2026-08-28